Oculis Holding AG Warrants
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-opht… Read more
Market Cap & Net Worth: Oculis Holding AG Warrants (OCSAW)
Oculis Holding AG Warrants (NASDAQ:OCSAW) has a market capitalization of $162.21K ($162.21K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #39934 globally and #12984 in its home market, demonstrating a 0.40% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oculis Holding AG Warrants's stock price $16.43 by its total outstanding shares 9873 (9.87K).
Oculis Holding AG Warrants Market Cap History: 2023 to 2026
Oculis Holding AG Warrants's market capitalization history from 2023 to 2026. Data shows growth from $14.81K to $162.21K (252.99% CAGR).
Oculis Holding AG Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oculis Holding AG Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OCSAW by Market Capitalization
Companies near Oculis Holding AG Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to Oculis Holding AG Warrants by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Oculis Holding AG Warrants Historical Marketcap From 2023 to 2026
Between 2023 and today, Oculis Holding AG Warrants's market cap moved from $14.81K to $ 162.21K, with a yearly change of 252.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $162.21K | +91.94% |
| 2025 | $84.51K | +58.81% |
| 2024 | $53.22K | +259.33% |
| 2023 | $14.81K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Oculis Holding AG Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $162.21K USD |
| MoneyControl | $162.21K USD |
| MarketWatch | $162.21K USD |
| marketcap.company | $162.21K USD |
| Reuters | $162.21K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.